Inhibition of T-cell reactivity to myasthenogenic epitopes of the human acetylcholine receptor by synthetic analogs.

Documenti analoghi

• Peptide analogs to pathogenic epitopes of the human acetylcholine receptor alpha subunit as potential modulators of myasthenia gravis.
  di: Zisman, E, et al.
  Pubblicazione: (1996)
• A peptide composed of tandem analogs of two myasthenogenic T cell epitopes interferes with specific autoimmune responses
  di: Katz-Levy, Yael, et al.
  Pubblicazione: (1997)
• Altered peptide ligands act as partial agonists by inhibiting phospholipase C activity induced by myasthenogenic T cell epitopes
  di: Faber-Elmann, Anat, et al.
  Pubblicazione: (1998)
• Oral administration of a dual analog of two myasthenogenic T cell epitopes down-regulates experimental autoimmune myasthenia gravis in mice
  di: Paas-Rozner, Miri, et al.
  Pubblicazione: (2000)
• The autoimmune response of different mouse strains to T-cell epitopes of the human acetylcholine receptor alpha subunit.
  di: Brocke, S, et al.
  Pubblicazione: (1990)